Literature DB >> 24653027

Virology. Epstein-Barr virus turns 50.

Paul M Lieberman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24653027      PMCID： PMC4581426          DOI： 10.1126/science.1252786

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

Review 2.  Delivering on the promise: HPV vaccines and cervical cancer.

Authors:  John T Schiller; Philip Davies
Journal:  Nat Rev Microbiol       Date:  2004-04       Impact factor: 60.633

3.  Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas.

Authors:  Ming-Han Tsai; Ana Raykova; Olaf Klinke; Katharina Bernhardt; Kathrin Gärtner; Carol S Leung; Karsten Geletneky; Serkan Sertel; Christian Münz; Regina Feederle; Henri-Jacques Delecluse
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

Review 4.  T-cell therapy in the treatment of post-transplant lymphoproliferative disease.

Authors:  Catherine M Bollard; Cliona M Rooney; Helen E Heslop
Journal:  Nat Rev Clin Oncol       Date:  2012-07-17       Impact factor: 66.675

5.  Addressing the growing international challenge of cancer: a multinational perspective.

Authors:  Harold Varmus; Harpal S Kumar
Journal:  Sci Transl Med       Date:  2013-03-06       Impact factor: 17.956

6.  Epstein-Barr virus: an important vaccine target for cancer prevention.

Authors:  Jeffrey I Cohen; Anthony S Fauci; Harold Varmus; Gary J Nabel
Journal:  Sci Transl Med       Date:  2011-11-02       Impact factor: 17.956

7.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 8.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

9.  Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.

Authors:  Etienne M Sokal; Karel Hoppenbrouwers; Corinne Vandermeulen; Michel Moutschen; Philippe Léonard; Andre Moreels; Michèle Haumont; Alex Bollen; Françoise Smets; Martine Denis
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

Review 10.  The curious case of the tumour virus: 50 years of Burkitt's lymphoma.

Authors:  David A Thorley-Lawson; Martin J Allday
Journal:  Nat Rev Microbiol       Date:  2008-12       Impact factor: 60.633
View more
  35 in total

1.  Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.

Authors:  Julianna S Deakyne; Kimberly A Malecka; Troy E Messick; Paul M Lieberman
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

2.  Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells.

Authors:  Dan Xiong; Yong Du; Hong-Bo Wang; Bo Zhao; Hua Zhang; Yan Li; Li-Juan Hu; Jing-Yan Cao; Qian Zhong; Wan-Li Liu; Man-Zhi Li; Xiao-Feng Zhu; Sai Wah Tsao; Lindsey M Hutt-Fletcher; Erwei Song; Yi-Xin Zeng; Elliott Kieff; Mu-Sheng Zeng
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-19       Impact factor: 11.205

3.  Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.

Authors:  Bradley M Haverkos; Alejandro A Gru; Susan M Geyer; Anissa K Bingman; Jessica A Hemminger; Anjali Mishra; Henry K Wong; Preeti Pancholi; Aharon G Freud; Michael A Caligiuri; Robert A Baiocchi; Pierluigi Porcu
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-08

4.  Human oncogenic viruses: nature and discovery.

Authors:  Yuan Chang; Patrick S Moore; Robin A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

5.  Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.

Authors:  Yonggang Pei; Rajnish Kumar Singh; Sanket Kumar Shukla; Fengchao Lang; Shengwei Zhang; Erle S Robertson
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

6.  Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.

Authors:  Luopin Wang; Jun Laing; Bingyu Yan; Hufeng Zhou; Liangru Ke; Chong Wang; Yohei Narita; Zonghao Zhang; Matthew R Olson; Behdad Afzali; Bo Zhao; Majid Kazemian
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

7.  CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.

Authors:  Yijie Ma; Michael J Walsh; Katharina Bernhardt; Camille W Ashbaugh; Stephen J Trudeau; Isabelle Y Ashbaugh; Sizun Jiang; Chang Jiang; Bo Zhao; David E Root; John G Doench; Benjamin E Gewurz
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

8.  Chromatin Remodeling Factor LSH Drives Cancer Progression by Suppressing the Activity of Fumarate Hydratase.

Authors:  Xiaozhen He; Bin Yan; Shuang Liu; Jiantao Jia; Weiwei Lai; Xing Xin; Can-E Tang; Dixian Luo; Tan Tan; Yiqun Jiang; Ying Shi; Yating Liu; Desheng Xiao; Ling Chen; Shao Liu; Chao Mao; Gang Yin; Yan Cheng; Jia Fan; Ya Cao; Kathrin Muegge; Yongguang Tao
Journal:  Cancer Res       Date:  2016-06-14       Impact factor: 12.701

Review 9.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

10.  Clinical Features of Intestinal Ulcers Complicated by Epstein-Barr Virus Infection: Importance of Active Infection.

Authors:  Yuyuan Liu; Yuqin Li; Yajun Li; Shuang Wu; Xinyue Tian; Tongyu Tang; Haibo Sun; Chuan He
Journal:  Dis Markers       Date:  2021-05-03       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.